Vaccine safety

Issue title: Special Issue: Vaccines

Article type: Research Article

Authors: Labadie, Jerry

Affiliations: WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden

Note: [] Address for correspondence: Jerry Labadie, MD, Vaccine Safety Specialist, Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Box 1051, 751 40 Uppsala, Sweden. E-mail: [email protected]

Abstract: Brief reports are presented on Swissmedic's experiences with PaniFlow™, a tool to monitor Adverse Events Following Immunization (AEFI) of pandemic influenza (H1N1) 2009 vaccines and UMC's updates on AEFI of these vaccines; on WHO's Global Network for Post-marketing Surveillance of Prequalified Vaccines and India joining the network; the June 2010 meeting of the Global Advisory Committee on Vaccine Safety.

Keywords: Vaccine, AEFI, A/H1N1, prequalified vaccines, GACVS

DOI: 10.3233/JRS-2011-0524

Journal: International Journal of Risk & Safety in Medicine, vol. 23, no. 2, pp. 113-115, 2011